Apolipoprotein E and presenilin-1 allelic variation and Alzheimer's disease in India

Human Biology

Volumn 74, Issue 5, 2002, Pages 683-693

  Chandak, G R ^a   Sridevi, M Uma ^a   Vas, C J ^b   Panikker, D M ^b   Singh, L ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b Holy Family Hospital   (India)

Author keywords

Allele and genotype frequency; Alzheimer's disease; APOE E*4 allele; Dementia; PS 1 polymorphism

Indexed keywords

EID: 0036815451     PISSN: 00187143     EISSN: None     Source Type: Journal    
DOI: 10.1353/hub.2002.0051     Document Type: Article

References (44)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association.
2. V717F transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 96:15233-15238.
3. Chandra, V., M. Ganguli, R. Pandav et al. 1998. Prevalence of Alzheimer's disease and other dementias in rural India. Neurology 51:1000-1008.
4. 4 and the risk of Alzheimer disease in late onset families. Science 261:921-923.
5. Daniel, W.W. 1995. The chi-square distribution and the analysis of frequencies. In Biostatistics: A Foundation for Analysis in the Health Sciences. 6th Ed. New York, NY: John Wiley & Sons, 503-566.
6. 4 and incidence of Alzheimer disease in a community population of older persons. J. Am. Med. Assn. 277:822-824.
7. Farrer, L.A., L.A. Cupples, J.L. Haines et al. 1997. Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. J. Am. Med. Assn. 278:1349-1356.
8. Folstein M.F., S.E. Folstein, and P.R. McHugh 1975. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:189-198.
9. Ganguli, M., G. Ratcliff, V. Chandra et al. 1995. A Hindi version of the MMSE: The development of a cognitive screening instrument for a largely illiterate elderly population in India. Int. J. Geriatr. Psychiatry 10:367-377.
10. Ganguli, M., V. Chandra, I. Kamboh et al. 2000. Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US cross-national dementia study. Arch. Neurol. 57:824-830.
11. Goate, A.M., M.C. Chartier-Harlin, M.C. Mullan et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
12. Gounden, N., J. Naidoo, R.J. Pegoraro et al. 1995. Apolipoprotein E allele frequencies in a South African Indian female population. Clin. Genet. 48:243-245.
13. Hallman, D.M., E. Boerwinkle, N. Saha et al. 1991. The Apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49:338-349.
14. Hardy, J. 1997. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosc. 20:154-159.
15. Higuchi, S., T. Muramatsu, S. Matsushita et al. 1996. Letter. Lancet 347:154-159.
16. Hixson, J.E., and D.T. Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31:545-548.
17. Hughes, C.P., L. Beryl, W.L. Danziger et al. 1982. A new clinical scale for the staging of dementia. Br. J. Psychiatry 140:566-572.
18. Isoe, K., K. Urakami, Y. Ji et al. 1996. Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population. Acta Neurol. Scand. 94:326-328.
19. Kehoe, P., J. Williams, P. Holmans et al. 1996. Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease. Neuro. Report 7:2155-2158.
20. Lazzari, R., A. Franzese, S.M. Chierichetti et al. 1983. Aging brain and ergot alkaloids. In Aging, Vol. 23, A. Agnoli, G. Crepaldi, P.F. Spano et al., eds. New York, NY: Raven Press, 347-371.
21. Levy-Lahad, E., W. Wasco, P. Poorkaj et al. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977.
22. Liao, A., T. Gomez-Isla, A. Clatworthy et al. 1999. Lack of association of presenilin-1 intron-8 polymorphism with neuropathological features of Alzheimer's disease. Brain Res. 816:295-298.
23. Mandelkow, E.M., and E. Mandelkow. 1998. Tau in Alzheimer's disease. Trends in Cell Biol. 8:425-427.
24. Mastana, S.S., R. Calderon, J. Pena et al. 1998. Anthropology of the Apolipoprotein E (Apo E) gene: Low frequency of apo E4 allele in Basques and in tribal (Baiga) populations of India. Ann. Hum. Biol. 25:137-143.
25. Matejcek, M., K. Knor, P.V. Piguet et al. 1979. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation. J. Amer. Geriat. Soc. 27:198-202.
26. Matsushita, S., H. Arai, T. Muramatsu et al. 1997. Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia. Exp. Neurol. 146:567-569.
27. McKhann, G., D. Drachman, M.F. Folstein et al. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944.
28. Payami, H., H. Grimslid, B. Oken et al. 1997. A prospective study on cognitive health in the elderly (Oregon Brain Ageing Study): Effects of family history and apolipoprotein E genotype. Am. J. Hum. Genet. 60:948-956.
29. Raber, J., D. Wong, M. Buttuni et al. 1998. Isoform specific effects of human apolipoprotein E on brain function revealed in ApoE knock out mice: Increased susceptibility of females. Proc. Natl. Acad. Sci. USA 95:10914-10919.
30. Rajkumar, S., S. Kumar, and R. Thara. 1997. Prevalence of dementia in a rural setting: A report from India. Int. J. Geriatr. Psychiatry 12:702-707.
31. Ramachandran, V., M.S. Menon, and B. Ramamurthy. 1981. Family structure and mental illness in old age. Ind. J. Psychiatry 23:21-26.
32. Selkoe, D.J. 1994. Cell biology of the Aβ-protein precursor and the mechanism of AD. Ann. Rev. Cell Biol. 10:373-403.
33. Selkoe, D.J., and M.S. Wolfe. 2000. In search of γ-secretase: Presenilin at the cutting edge. Proc. Natl. Acad. Sci. USA 97:5690-5692.
34. Shaji, S., K. Promodu, A. Tony et al. 1996. An epidemiological study of dementia in a rural community in Kerala, India. Br. J. Psychiatry 168:745-749.
35. Sherrington, R., E.I. Rogaev, Y. Liang et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
36. 4 and the risk of dementia with stroke. J. Am. Med. Assn. 277:818-821.
37. Sodeyama, N., Y. Itoh, N. Suematsu et al. 1998. Presenilin-1 intronic polymorphism is not associated with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 64:548-551.
38. Strittmatter, W.J., A.M. Saunders, D. Schmechel et al. 1999. Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 96:15233-15238.
39. Strooper, B.D. 2000. Closing in on γ-secretase. Nature 405:627-629.
40. 4 allele and the risk of AD among African Americans, Whites and Hispanics. J. Am. Med. Assn. 279:751-755.
41. Vas, C. J., C. Pinto, D. Panikker et al. 2001. Prevalence of dementia in an urban Indian population. Int. Psychogeriatr. 13:439-450.
42. VanDuijn, C.M., P. deKnijff, M. Cruts et al. 1994. Apolipoprotein E allele in a population-based study of early-onset Alzheimer's disease. Nat. Genet. 7:74-78.
43. Venn, R.D. 1983. The Sandoz Clinical Assessment Geriatric Scale: A general purpose psychogeriatric rating scale. Gerontology 29:185-198.
44. Wragg, M., M. Hutton, and C. Talbot, the AD collaborative group. 1996. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 347:509-512.